Opioids Market Report
Description
According to IMARC Group’s latest report, titled “Opioids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global opioids market reached a value of US$ XX Billion in 2020. Opioids stand for the drugs that are used to control persistent and severe pain among patients suffering from chronic headaches and backaches. They interact with proteins in the spinal cord, gut, brain, and other body parts to block pain signals. Opioids are either extracted from poppy seeds or synthesized in the laboratory. They are generally available in the form of pills or as tablets. Opioids can also be administered into the veins via an intravenous (IV) injection or infusion and taken through oral and transdermal routes, wherein active ingredients are delivered across the skin for systemic distribution.
Request for a PDF sample of this report: https://www.imarcgroup.com/opioids-market/requestsample
The increasing prevalence of cancer due to excessive tobacco and alcohol consumption and instances of obesity, human papillomavirus (HPV), and multiple sunburns is one of the key factors driving the opioids market. Besides this, the elevating participation of children in professional sports and physical activities has led to a rise in severe injuries, which, in turn, is also propelling the market growth. Additionally, the increasing number of individuals undergoing surgical interventions is escalating the demand for opioids to help manage pain and speed recovery. Moreover, growing investments in research and development (R&D) activities to assess the efficacy and safety of opioids in new diseases are anticipated to catalyze the market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Boehringer Ingelheim International GmbH
- Hikma Pharmaceuticals PLC
- Mallinckrodt plc
- Pfizer Inc.
- Purdue Pharma L.P.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Market Segmentation:
Breakup by Product Type:
- Codeine
- Fentanyl
- Methadone
- Oxycodone
- Morphine
- Hydrocodone
Breakup by Application:
- Pain Management
- Cough Treatment
- Diarrhea Treatment
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Stores
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/30kaDq9
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
